EGRP News Flash - January 3, 2013

Funding Opportunity for Collaborative Activities to Promote Metabolomics Research

The National Institute of Health's (NIH) Common Fund Metabolomics Program recently announced an Administrative Supplement Funding Opportunity Announcement (FOA) to increase and improve the nation's ability to undertake metabolomics analyses in translational and clinical research. Metabolomics has great potential to advance our understanding of human diseases, but requires specialized expertise in metabolomics study design, technology, and data analysis and interpretation. This FOA supports supplemental funds to current NIH-funded research projects for new interactive collaborations between basic or clinical researchers and metabolomics experts to pursue biomedical studies requiring a metabolomics approach and increase metabolomics expertise in the biomedical research community.

All applicants are encouraged to discuss potential requests with the awarding NIH Institute or Center. Applications are due March 15, 2013, by 5:00 P.M. local time of applicant organization.

Learn more about the NIH Common Fund Metabolomics ProgramExternal Web Site Policy.

For cancer epidemiology questions related to metabolomics, contact EGRP's Joseph Su, Ph.D., M.P.H., Program Director, Modifiable Risk Factors Branch; or Krista Zanetti, Ph.D., M.P.H., R.D., Program Director, Host Susceptibility Factors Branch.

Access the NIH Guide for Grants and Contracts for details:

Return to Top